Alan Brochstein, The Cannabis Capitalist
Alan Brochstein, CFA, covers the cannabis industry full time from Houston, running 420 Investor, a subscription-based service for those interested in publicly-traded cannabis stocks, and New Cannabis Ventures, a news and information platform that highlights promising companies and influential investors in the cannabis industry. Before focusing on the cannabis industry in 2013, Alan worked as an independent equity research analyst following two decades as a portfolio manager, trader, and analyst.
Showing 6 articles for

Investing: Canopy Growth & MedReleaf Rally Past Weak Near-Term Results

Both companies missed analysts' revenue predictions, but investors didn't seem to care.

Cannabis Investing: Does Revenue Even Matter?

Revenue generation isn't always rewarded by the stock market. Here's how to read revenue figures, and why you should dive deeper before investing.

3 Canadian Companies Are Making Big US Cannabis Investments

Canadian Bioceutical, iAnthus Capital, and Liberty Health Sciences are moving capital south of the border.

Investing in Cannabis? Consider Going Global With Canadian Companies

Use the loonie to invest overseas: Canadian companies are involved in cannabis ventures on five continents.

5 Ways to Avoid Cannabis Stock Investment Scams

Are those 'employees' just models? Does the phone go straight to voicemail? Look for these and other red flags.

Investing in Cannabis? Ask These 3 Questions Before You Do

Leafly's new columnist, Alan Brochstein, separates the contenders from the pretenders. Meet the Cannabis Capitalist.